Oral antiviral treatment for COVID-19 in patients with systemic autoimmune rheumatic diseases. Gerolymatou N, Bakasis AD, Voulgari PV, Vlachoyiannopoulos PG, et al. J Rheumatol 2022 Dec 15:jrheum.221014. doi: 10.3899/jrheum.221014.

Read + Share

Amedeo Smart

Independent Medical Education

Gerolymatou N, Bakasis AD, Voulgari PV, Vlachoyiannopoulos PG, et al. Oral antiviral treatment for COVID-19 in patients with systemic autoimmune rheumatic diseases. J Rheumatol 2022 Dec 15:jrheum.221014. doi: 10.3899/jrheum.221014.
PMID: 36521909